Hirsch FR - Search Results

1

IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001.

Hirsch FR, Bunn PA Jr, Dmitrovsky E, Field JK, Franklin WA, Greenberg RE, Hansen HH, Henschke CI, Rigas JR, Smith RA, Toennesen P, Mulshine JL. Hirsch FR, et al. Lung Cancer. 2002 Sep;37(3):325-44. doi: 10.1016/s0169-5002(02)00141-1. Lung Cancer. 2002. PMID: 12234703 No abstract available.

2

Computed tomography screening for lung cancer: what should we recommend?

Byers T, Hirsch FR. Byers T, et al. Among authors: hirsch fr. Cancer Pract. 2001 Mar-Apr;9(2):97-9. doi: 10.1046/j.1523-5394.2001.009002097.x. Cancer Pract. 2001. PMID: 11879285 No abstract available.

3

Epidermal growth factor receptor family in lung cancer and premalignancy.

Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA Jr. Franklin WA, et al. Among authors: hirsch fr. Semin Oncol. 2002 Feb;29(1 Suppl 4):3-14. doi: 10.1053/sonc.2002.31520. Semin Oncol. 2002. PMID: 11894009 Review.

4

HER2/neu expression in malignant lung tumors.

Hirsch FR, Franklin WA, Veve R, Varella-Garcia M, Bunn PA Jr. Hirsch FR, et al. Semin Oncol. 2002 Feb;29(1 Suppl 4):51-8. doi: 10.1053/sonc.2002.31523. Semin Oncol. 2002. PMID: 11894014

5

The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis.

Bremnes RM, Veve R, Hirsch FR, Franklin WA. Bremnes RM, et al. Among authors: hirsch fr. Lung Cancer. 2002 May;36(2):115-24. doi: 10.1016/s0169-5002(01)00471-8. Lung Cancer. 2002. PMID: 11955645 Review.

6

What is the role of HER-2/neu and trastuzumab (Herceptin) in lung cancer?

Hirsch FR, Franklin WA, Bunn PA. Hirsch FR, et al. Lung Cancer. 2002 Jun;36(3):263-4. doi: 10.1016/s0169-5002(02)00011-9. Lung Cancer. 2002. PMID: 12009235 No abstract available.

7

Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.

Hirsch FR, Helfrich B, Franklin WA, Varella-Garcia M, Chan DC, Bunn PA Jr. Hirsch FR, et al. Clin Breast Cancer. 2002 May;3 Suppl 1:12-6. doi: 10.3816/cbc.2002.s.003. Clin Breast Cancer. 2002. PMID: 12057039 Review.

8

Expression of target molecules in lung cancer: challenge for a new treatment paradigm.

Hirsch FR, Franklin WA, Bunn PA Jr. Hirsch FR, et al. Semin Oncol. 2002 Jun;29(3 Suppl 9):2-8. doi: 10.1053/sonc.2002.34265. Semin Oncol. 2002. PMID: 12094332 Review.

9

Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations.

Field JK, Brambilla C, Caporaso N, Flahault A, Henschke C, Herman J, Hirsch F, Lachmann P, Lam S, Maier S, Montuenga LM, Mulshine J, Murphy M, Pullen J, Spitz M, Tockman M, Tyndale R, Wistuba I, Youngson J. Field JK, et al. Int J Oncol. 2002 Aug;21(2):369-73. doi: 10.3892/ijo.21.2.369. Int J Oncol. 2002. PMID: 12118333 Review.

10

Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.

Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA. Sugita M, et al. Among authors: hirsch fr. Cancer Res. 2002 Jul 15;62(14):3971-9. Cancer Res. 2002. PMID: 12124329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters